Command Palette

Search for a command to run...

ONESOURCE
1841.8(-0.97%)
1W: +1.20%

Peers

Snapshot Summary

Onesource Specialty Pharma Ltd. is significantly underperforming across all key financial metrics compared to its peers in the Pharmaceuticals & Drugs sector. Companies like Cipla Ltd. and Sun Pharmaceutical Industries Ltd. show strong profitability and growth, making them sector leaders, while Onesource is financially weak with negative margins and high debt levels.

  • • Onesource has the lowest revenue growth, EPS, ROE, ROA, and profitability metrics.
  • • Cipla and Sun Pharmaceutical stand out as top performers in profitability and valuation metrics.
  • • Onesource’s extremely high P/E ratio indicates it is overvalued compared to peers.
  • • Cipla Ltd.: Highest ROE and EBITDA margin, strong growth in revenue and EPS.
  • • Sun Pharmaceutical Industries Ltd.: Strong revenue growth and profitability metrics, low debt levels.
  • • Dr. Reddy's Laboratories Ltd.: Consistent growth in revenue, EPS, and strong profitability metrics.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ONESOURCE₹1,882.70₹21,550.52Cr1077.55-21.41%1.45
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
Explore
Watchlists
Chat
Portfolio